Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Prostate Cancer

In brief

RATIONALE: Soy protein may help prevent prostate cancer recurrence in patients who have undergone surgery for prostate cancer. PURPOSE: This randomized phase II/III trial is studying how well soy protein works and compares it to a placebo in preventing recurrent cancer in patients who have undergone surgery for stage II prostate cancer.

Key facts

Study ID

NCT00765479

Run by

University of Illinois at Chicago

People needed

284

Starts

2006-12-01

Expected to finish

2013-07-01

Last updated by the study team

2013-09-20

Who can join

Age: 40 and older, up to 75. Sex: male. Healthy volunteers: not accepted.

Where it is running

• University of Illinois Cancer Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.